Catheter Precision (VTAK) Amortization of Deferred Charges (2025 - 2026)

Catheter Precision's (VTAK) quarterly Amortization of Deferred Charges came in at $97000.0 in Q1 2026, up 321.74% year-on-year from $23000.0 in Q1 2025, and up 438.89% on a QoQ basis from $18000.0 in Q4 2025.

Catheter Precision (VTAK) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends

Catheter Precision (VTAK) has 2 years of Amortization of Deferred Charges data on file, last reported at $97000.0 in Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges rose 321.74% year-over-year to $97000.0 in Q1 2026; TTM through Mar 2026 was $119000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $45000.0, changed N/A from the prior year.
  • Amortization of Deferred Charges for Q1 2026 stood at $97000.0, up from $18000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for VTAK reached as high as $97000.0 in Q1 2026 and fell as low as -$13000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.66 Bn 175.36 Bn 6.27 Bn
2 Stryker 128.55 Bn 125.68 Bn 3.81 Bn
3 Medtronic 108.38 Bn 99.16 Bn 6.41 Bn
4 Boston Scientific 68.11 Bn 66.66 Bn 3.61 Bn
5 Edwards Lifesciences 47.19 Bn 43.52 Bn 1.29 Bn
6 Dexcom 28.54 Bn 27.42 Bn 750.30 Mn
7 GE HealthCare Technologies 28.37 Bn 26.09 Bn 1.98 Bn
8 Smith & Nephew 26.90 Bn 26.33 Bn -
9 Koninklijke Philips 25.53 Bn 22.40 Bn 2.07 Bn
10 Catheter Precision 610,863.29 210,863.29 390,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 97,000.00
Mar 31, 2026 97,000.00
Dec 31, 2025 18,000.00
Dec 31, 2025 18,000.00
Sep 30, 2025 17,000.00
Sep 30, 2025 17,000.00
Jun 30, 2025 -13,000.00
Jun 30, 2025 -13,000.00
Mar 31, 2025 23,000.00
Mar 31, 2025 23,000.00